Crispr Therapeutics (CRSP) - News Mentions

Sign up to add (CRSP) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 0%
Gilead Sciences
Gilead Sciences
GILD		 3 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?
November 5
CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates
November 5
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates
November 4
CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average
November 3
CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average
November 3
Is CRISPR Therapeutics (CRSP) a Promising Gene Editing Stock?
October 30
CRISPR Therapeutics (NASDAQ:CRSP) Upgraded to Sell at StockNews.com
October 30
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by PFG Investments LLC
October 30
CRISPR Therapeutics (NASDAQ:CRSP) Raised to "Sell" at StockNews.com
October 29
Crispr Therapeutics: Avoid Catching The Falling Knife This Time (Downgrade)
October 29
Crispr Therapeutics: Poised For A Major Turnaround
October 27
Hennion & Walsh Asset Management Inc. Buys 5,567 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
October 26
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note
October 25
Interesting CRSP Put And Call Options For December 6th
October 23
Cathie Wood’s ARK Investment bought 47.8K shares of Crispr Therapeutics today
October 21
Cathie Wood's ARK Investment bought 47.8K shares of Crispr Therapeutics today
October 21

Month over Month

Est. daily news mentions.

Oct 2024 0
Sep 2024 0
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is Crispr Therapeutics mentioned in the news?

Crispr Therapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Crispr Therapeutics performing compared to its industry peers?

Crispr Therapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Crispr Therapeutics in the last month?

There has been no significant change in the number of news mentions for Crispr Therapeutics' compared to the last month.

Why is it important to track news mentions for Crispr Therapeutics?

By monitoring mentions in the news for Crispr Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Crispr Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Crispr Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact